Cargando…
Lenalidomide-Induced Diffuse Alveolar Hemorrhage in Patient With Multiple Myeloma
We present a case of multiple myeloma that was treated with a regimen that included lenalidomide. Lenalidomide, a thalidomide analog, is an immunomodulatory drug created synthetically by changing the chemical makeup of thalidomide to increase efficacy and lessen negative effects. It has been authori...
Autores principales: | Qanash, Sultan, Alamoudi, Sameer, Alsuraihi, Anas, Jafri, Asif, Malakah, Manar A, Baghlaf, Bayan, Alamoudi, Mulukah, Althobaiti, Mohammad M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491948/ https://www.ncbi.nlm.nih.gov/pubmed/37692720 http://dx.doi.org/10.7759/cureus.43250 |
Ejemplares similares
-
Co-Occurring Hemolysis and Methemoglobinemia After COVID-19 Infection in Patient With G6PD Deficiency
por: Malakah, Manar A, et al.
Publicado: (2023) -
Lenalidomide-induced diffuse alveolar hemorrhage
por: Saheer, S., et al.
Publicado: (2014) -
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
por: Botta, Cirino, et al.
Publicado: (2021) -
A 68-Year-Old Man with a Cytogenetic Diagnosis of Chronic Myeloid Leukemia and Bone Marrow Findings of Philadelphia Chromosome Translocation Between the Long Arm of Chromosomes 9 and 22, Leading to the BCR-ABL1 Fusion Gene and V617F Mutation in the JAK2 Gene
por: Warsi, Ashraf, et al.
Publicado: (2023) -
Computerized intraligamental anesthesia in children: A review of clinical considerations
por: Baghlaf, Khlood, et al.
Publicado: (2018)